ConductScience.org, home

Paper6284643

In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes.

Naylor PT and 3 others. Infect Immun, 1982. Cited by 43 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes. Papers, record 6284643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6284643

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes.
PubMed
Journal
Infect Immun
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
1.42
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Naylor PTP T
2Larsen HSH S
3Huang LL
4Rouse BTB T

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
Antigens, ViralMajor topic
SimplexvirusMajor topic
Adjuvants, Immunologic
Animals
Female
Lipid A
Liposomes
Mice

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI 14981NIAID NIH HHSUnited StatesR01AI014981PubMed and NIHNIH RePORTER
CA 23553NCI NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1240860Interaction of phospholipid vesicles with cultured mammalial cells. I. Characteristics of uptake.J Cell Biol1975https://conductscience.org/library/papers/240860PubMed
26244225Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes.Infect Immun1980https://conductscience.org/library/papers/6244225PubMed
37399568Liposomes in immunology: multilamellar phosphatidylcholine liposomes as a simple, biodegradable and harmless adjuvant without any immunogenic activity of its own.Immunol Commun1980https://conductscience.org/library/papers/7399568PubMed
4311343Stimulation of T-independent antibody responses by hapten-lipopolysaccharides without repeating polymeric structure.Infect Immun1979https://conductscience.org/library/papers/311343PubMed
56971170A study of the inability of subcellular fractions to elicit primary anti-H-2 cytotoxic T lymphocytes.Cell Immunol1981https://conductscience.org/library/papers/6971170PubMed
6392087Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.J Reticuloendothel Soc1979https://conductscience.org/library/papers/392087PubMed
75804498A new method for the extraction of R lipopolysaccharides.Eur J Biochem1969https://conductscience.org/library/papers/5804498PubMed
86969745Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes.J Immunol1981https://conductscience.org/library/papers/6969745PubMed
94367302A temperature-sensitive mutant of herpes simplex virus type 1 defective in the synthesis of the major capsid polypeptide.J Gen Virol1974https://conductscience.org/library/papers/4367302PubMed
1014450081Preparation of iodine-131 labelled human growth hormone of high specific activity.Nature1962https://conductscience.org/library/papers/14450081PubMed
11310517Effective subunit vaccines against an enveloped animal virus.Nature1978https://conductscience.org/library/papers/310517PubMed
1213813473Estimation of 3-deoxy sugars by means of the malonaldehyde-thiobarbituric acid reaction.Nature1960https://conductscience.org/library/papers/13813473PubMed
13641340Effect of liposomal model membrane composition on immunogenicity.J Immunol1978https://conductscience.org/library/papers/641340PubMed
146274793The role of accessory cells and T cell-growth factor in induction of cytotoxic T lymphocytes against herpes simplex virus antigens.Immunology1981https://conductscience.org/library/papers/6274793PubMed
156245140Induction of cytotoxic T lymphocytes against herpes simplex virus type i: role of accessory cells and amplifying factor.J Immunol1980https://conductscience.org/library/papers/6245140PubMed
1647220Delayed hypersensitivity in the mouse.Adv Immunol1975https://conductscience.org/library/papers/47220PubMed
17334973Immunogenic properties of liposomal model membranes in mice.J Immunol1977https://conductscience.org/library/papers/334973PubMed
18448082Production of antibodies against phosphocholine, phosphatidylcholine, sphingomyelin, and lipid A by injection of liposomes containing lipid A.J Immunol1979https://conductscience.org/library/papers/448082PubMed
19217506Mechanisms of recovery from Herpesvirus infections -a review.Can J Comp Med1978https://conductscience.org/library/papers/217506PubMed
20334974Enhancement of liposomal model membrane immunogenicity by incorporation of lipid A.J Immunol1977https://conductscience.org/library/papers/334974PubMed

See all 27 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
15258310Mucosal immunity: overcoming the barrier for induction of proximal responses.Immunol Res2004https://conductscience.org/library/papers/15258310PubMed
7719272Liposomes as delivery systems in the prevention and treatment of infectious diseases.Pharm World Sci1995https://conductscience.org/library/papers/7719272PubMed
6309441Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.Clin Exp Immunol1983https://conductscience.org/library/papers/6309441PubMed
6307874Comparison of effects of adjuvants on efficacy of virion envelope herpes simplex virus vaccine against labial infection of BALB/c mice.Infect Immun1983https://conductscience.org/library/papers/6307874PubMed
6299949Frequency of cytotoxic T lymphocyte precursors to herpes simplex virus type 1 as determined by limiting dilution analysis.Infect Immun1983https://conductscience.org/library/papers/6299949PubMed
3277918Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen.Infect Immun1988https://conductscience.org/library/papers/3277918PubMed
2153234
Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccines.
J Virol1990https://conductscience.org/library/papers/2153234PubMed
2019429
Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.
Infect Immun1991https://conductscience.org/library/papers/2019429PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6284643

GET https://conductscience.org/api/papers/v1/6284643/references?page=2